Clinical trial
A Multicenter, Post Market, Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ Intertrochanteric Antegrade Nails (10S Models) for the Treatment of Femoral Fracture in Chinese Subjects
NCT04865146 is registered in ClinicalTrials.gov with Smith & Nephew Medical (Shanghai) Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Post Market, Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ Intertrochanteric Antegrade Nails (10S Models) for the Treatment of Femoral Fracture in Chinese Subjects
- Lead sponsor
- Smith & Nephew Medical (Shanghai) Ltd
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- June 23, 2022
- Completion date
- January 31, 2025
- Enrollment
- 0 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.